Abstract
This review focuses on Eating Disorders (ED), the role played by neurotransmitters and peptides in ED phenomena as well as the drugs used in the treatment of these diseases. For ED, we mean a syndrome characterized by persistent alteration of eating behavior and the conditions that cause an insufficient ingestion and/or adsorption of foods. There are three different ED diseases: Anorexia Nervosa (AN), Bulimia Nervosa (BN) and Binge Eating Disorders (BED). ED are complex conditions that arise from a combination of long-standing behavioral, emotional, psychological, interpersonal, and social factors. The neuronal circuits that control the ingestion of food are mainly related to catecholaminergic, serotoninergic and peptidergic systems. In this respect, while serotonin, dopamine and prostaglandin promote the ingestion of food, by contrast, neuropeptide Y, norepinephrine, GABA and opioid peptides inhibit food ingestion, thus, causing the occurence of ED. The drugs mainly used in the treatment of ED are antidepressants such as selective serotonin reuptake inhibitors and tricyclic antidepressants. Additionally, mood stabilizers (lithium), anxiolytics, serotonin and noradrenalin reuptake inhibitors and antipsychotic drugs are often us...Continue Reading
Citations
Oct 5, 2011·Addiction Biology·Teresa Femenía, Jorge Manzanares
Dec 18, 2010·Neuromolecular Medicine·Joanna K SoczynskaRoger S McIntyre
Jan 27, 2016·Physiology & Behavior·Juliane Calvez, Elena Timofeeva
Jul 20, 2010·Journal of Nutrition Education and Behavior·Leehu Zysberg, Anna Rubanov
Sep 26, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chien-Han Lai
Nov 26, 2009·Obstetrics and Gynecology·Arnold E Andersen, Ginny L Ryan
Apr 24, 2009·Chemistry : a European Journal·Oliver GleesonStephen J Connon
Jun 9, 2009·Chemistry : a European Journal·Daniel PellicoM Rosario Torres
Jul 14, 2009·Angewandte Chemie·Eloísa Jiménez-NúñezAntonio M Echavarren
Jun 6, 2009·ChemMedChem·W Peter LippertReinhold Tacke
Jul 25, 2009·Angewandte Chemie·Alfonso García-RubiaJuan C Carretero
Feb 10, 2009·Angewandte Chemie·Pedro H C CamargoYounan Xia
Mar 13, 2009·Chemistry : a European Journal·Rita AnnunziataAndrea Mazzanti
Feb 27, 2010·Angewandte Chemie·Hitoshi HachiyaMasahiro Miura
May 29, 2014·British Journal of Pharmacology·M A van GestelS K Janhunen
Aug 21, 2013·ISRN Pharmacology·W MilanoA Capasso
Apr 23, 2013·Appetite·Fangli HouFangbiao Tao
Sep 25, 2010·Pharmacology, Biochemistry, and Behavior·Maria RazzoliRoberto Arban
Oct 10, 2013·International Journal of Endocrinology·Kvido SmitkaJara Nedvidkova
Oct 16, 2019·Angewandte Chemie·Guojiao WuAxel Jacobi von Wangelin
Apr 8, 2020·Angewandte Chemie·Jingjing ZhangHerbert Mayr
Apr 18, 2020·Angewandte Chemie·Biming MaoHongchao Guo
Aug 30, 2014·Chemistry : a European Journal·Joel MalmgrenBerit Olofsson
Mar 11, 2020·Angewandte Chemie·Hao ChenMengchun Ye
Oct 8, 2019·Chemistry : a European Journal·Wei YaoDawei Wang
May 19, 2020·Angewandte Chemie·Tatsuhiro Tsukamoto, Guangbin Dong
May 20, 2020·Angewandte Chemie·Jiuzhou GuoYanxing Jia
Apr 25, 2020·Angewandte Chemie·Jin Xie
Aug 7, 2020·Angewandte Chemie·Xinyao LiThorsten Bach
Feb 3, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Valerie H TaylorArya M Sharma
Oct 13, 2020·Frontiers in Pediatrics·Giorgia SebastianiOscar García-Algar
Oct 4, 2021·Journal of Eating Disorders·Sara SpadiniAntonio Malgaroli